Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus

Completed · Phase 2 · Has a placebo group

Conditions studied: Tinnitus

In brief

The purpose of the study is to evaluate the therapeutic benefit and safety of intratympanic AM-101 injections in comparison to placebo in the treatment of persistent acute inner ear tinnitus.

Key facts

Study ID
NCT01270282
Run by
Auris Medical, Inc.
People needed
82
Starts
2011-02-01
Expected to finish
2013-05-01
Last updated by the study team
2015-01-26

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.